TGA approves second COVID-19 vaccine for youngest children The Pfizer vaccine is now approved for use in children aged six months to five years, with Moderna already available to the age group.
Medicinal cannabis companies ‘undermined doctor–patient relationship’ Almost $1 million in fines have been issued to companies for unlawfully advertising prescription-only medicinal cannabis products.
WA RACGP Chair offered leadership scholarship Dr Ramya Raman has been offered a place at the McKinsey Young Leaders Forum 2022, which will take place in October.
Widespread concerns flagged about NPS MedicineWise demise Many worry about the impact on the safe use of medicine, while the transfer of skills is another key issue with employees already leaving.
TGA approves vaccine booster for primary school age children Pfizer’s COVID-19 vaccine has been given the green light as a booster for children aged 5–11, with ATAGI recommendations to follow.
Is enough done to deter violence in general practice? An encounter with an aggressive patient, and the fallout that ensued, was enough for one GP to consider moving away from the profession.
All excess deaths in Singapore linked to recent COVID infection: Study A new report from the country’s Ministry of Health attributes the increased death rate to COVID-19’s aggravation of existing illnesses.
Vaccine rollout ‘relied on GP goodwill’: Study General practices involved in Australia’s COVID-19 vaccination program struggled to make ends meet, researchers say.
Push for expansion of safe injecting facilities Researchers say ‘substantial evidence’ should encourage governments, in Australia and further afield, to facilitate more medically supervised sites.
Combined flu and COVID-19 tests approved Two separate nasal tests capable of detecting both COVID-19 and influenza have been approved by Australia’s medicines regulator.